natgillin/translations-raw huggingface dataset:
Immunisation should be postponed in subjects with a severe febrile illness or acute infection. 
Cepljenje je treba odložiti pri osebah s hudo vročinsko boleznijo ali akutno okužbo.
What you need to know before you receive Prepandrix 
Kaj morate vedeti, preden boste dobili cepivo Prepandrix
There is currently no evidence to indicate that Prepandrix may be associated with a risk of narcolepsy. 
Trenutno ni dokazov, da bi bilo cepivo Prepandrix morda povezano s tveganjem za narkolepsijo.
If a double dose is given, the injections should be given into opposite limbs. 
Če je uporabljen dvojni odmerek, je treba injekciji dati v nasprotni okončini.
• Generalised skin reactions including urticaria (hives) 
• generalizirane kožne reakcije, vključno z urtikarijo (koprivnico).
As with all vaccines, Prepandrix may not fully protect all persons who are vaccinated. 
Kot druga cepiva tudi cepivo Prepandrix morda ne bo popolnoma zaščitilo vseh cepljenih oseb.
Prepandrix is not intended to be given at the same time as some other vaccines. 
Cepivo Prepandrix ni namenjeno za dajanje ob istem času z nekaterimi drugimi cepivi.
Prepandrix can still be given but your response to the vaccine may be poor. 
Cepivo Prepandrix lahko dobite kljub temu, a vaš odziv nanj je lahko šibek.
Pharmacotherapeutic group: Influenza vaccines, ATC Code J07BB02 
Farmakoterapevtska skupina: Cepiva proti gripi, oznaka ATC: J07BB02
• They will give Prepandrix as an injection into a muscle. 
• Cepivo Prepandrix vam bodo injicirali v mišico.
The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP. 
Imetnik dovoljenja za promet z zdravilom bo izvedel farmakovigilančne aktivnosti, podrobno opisane v načrtu farmakovigilance, sprejetem v RMP, predloženem v modulu 1.8.2 vloge za pridobitev dovoljenja za promet z zdravilom in vseh nadaljnjih posodobitvah RMP
5 years 
5 let.
• From 80 years onwards: you may receive two double injections of Prepandrix. 
• Odrasli, starejši od 80 let: morda boste prejeli dve dvojni injekciji cepiva Prepandrix.
Prepandrix contains less than 1 mmol sodium (23 mg) and less than 1 mmol of potassium (39 mg) per dose. 
Cepivo Prepandrix vsebuje manj kot 1 mmol natrija (23 mg) in manj kot 1 mmol kalija (39 mg) na odmerek.
Other medicines and Prepandrix 
Druga zdravila in cepivo Prepandrix
Immunisation should be carried out by intramuscular injection preferably into the deltoid muscle or anterolateral thigh (depending on the muscle mass). 
Imunizacijo je treba opraviti z intramuskularno injekcijo, po možnosti v deltoidno mišico ali anterolateralni del stegna (odvisno od mišične mase).
What Prepandrix is and what it is used for 
Kaj je cepivo Prepandrix in za kaj ga uporabljamo
Control groups included ferrets immunized with adjuvant alone, non-adjuvanted vaccine (15 micrograms HA) or phosphate buffered saline solution. 
Kontrolne skupine so vključevale dihurje, ki so prejeli samo adjuvans, cepivo brez adjuvansa (15 mikrogramov HA) ali fiziološko raztopino fosfatnega pufra.
Epidemiological studies relating to another AS03-adjuvanted vaccine (Pandemrix H1N1, also manufactured in the same facility as Prepandrix), in several European countries have indicated an increased risk of narcolepsy with or without cataplexy in vaccinated as compared with unvaccinated individuals. 
Epidemiološke študije, povezane z drugim cepivom z adjuvansom AS03 (Pandemrix H1N1, ki ga prav tako izdeluje isti obrat kot cepivo Prepandrix), so v več evropskih državah nakazale večje tveganje za narkolepsijo (s katapleksijo ali brez nje) pri cepljenih osebah v primerjavi z necepljenimi.
2.5 ml per vial 
2,5 ml na vialo
50 vials: emulsion (adjuvant) 
50 vial: emulzija (adjuvans)
There are currently no data available on the use of Prepandrix in pregnancy. 
Trenutno ni podatkov o uporabi cepiva Prepandrix med nosečnostjo.
Tell the doctor requesting these tests that you have recently received Prepandrix. 
Zdravnika, ki želi opraviti takšne preiskave opozorite, da ste bili pred kratkim cepljeni s cepivom Prepandrix.
Animal studies with Prepandrix containing A/Vietnam/1194/2004 do not indicate reproductive toxicity (see section 5.3). 
Študije na živalih, opravljene s cepivom Prepandrix, ki vsebuje sev A/Vietnam/1194/2004, ne kažejo na vpliv na sposobnost razmnoževanja (glejte poglavje 5.3).
In adults 18 to 60 years of age, the most frequently reported adverse reactions after vaccination were injection site pain (76.6%), muscle aches (46.8%), fatigue (43.6%), headache (25.3%) and joint pain 
Pri odraslih v starosti od 18 do 60 let so bili najpogosteje zabeleženi neželeni učinki po cepljenju: bolečina na mestu injiciranja (76,6 %), boleče mišice (46,8 %), utrujenost (43,6 %), glavobol (25,3 %) in bolečine v sklepih (13,5 %).
• Increased sweating, shivering, flu-like symptoms 
• močnejše znojenje, drgetanje, gripi podobni simptomi,
*propagated in eggs **expressed in microgram haemagglutinin 
* namnožen v jajcih ** izražen v mikrogramih hemaglutinina
Prepandrix is a vaccine for use in adults from 18 years old. 
Kaj je cepivo Prepandrix in za kaj ga uporabljamo Cepivo Prepandrix uporabljamo pri odraslih, starejših od 18 let.
• From 18 years onwards: you will receive two doses of Prepandrix. 
• Odrasli, starejši od 18 let: prejeli boste dva odmerka cepiva Prepandrix.
Based on very limited data, adults aged >80 years may require a double dose of Prepandrix on an elected date and again after an interval of at least three weeks in order to achieve an immune response (see section 5.1). 
Na podlagi zelo omejenih podatkov kaže, da lahko odrasli, starejši od 80 let, potrebujejo za doseganje imunskega odziva dvojni odmerek cepiva Prepandrix na izbrani datum in znova po presledku vsaj treh tednov (glejte poglavje 5.1).
If any of the side effects below occur, please tell your doctor or nurse immediately: 
Če se pojavi kateri od spodaj navedenih neželenih učinkov, nemudoma obvestite zdravnika ali medicinsko sestro:
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to medical prescription. 
B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja cepiva je le na recept.
What Prepandrix is and what it is used for What you need to know before you receive Prepandrix How Prepandrix is given 
Kaj je cepivo Prepandrix in za kaj ga uporabljamo Kaj morate vedeti, preden boste cepljeni s cepivom Prepandrix Kako uporabljati cepivo Prepandrix
For instructions on mixing of the medicinal product before administration, see section 6.6. 
Za navodila o mešanju cepiva pred uporabo glejte poglavje 6.6.
However, following two administrations of a double dose of vaccine, the seroprotection rate at day 42 was 75%. 
Po dvakratni uporabi dvojnega odmerka cepiva pa je bil delež serološke zaščite 42. dan 75 %.
One pack of Prepandrix consists of: 
Eno pakiranje cepiva Prepandrix vsebuje:
The reproductive toxicity studies have been conducted using Prepandrix containing A/Vietnam/1194/2004. 
Študije toksičnih učinkov na sposobnost razmnoževanja so bile opravljene s cepivom Prepandrix, ki je vseboval A/Vietnam/1194/2004.
A minor infection such as a cold should not be a problem, but your doctor will advise whether you could still be vaccinated with Prepandrix. 
Blažja okužba, npr. prehlad, ne predstavlja težave, vendar se pred cepljenjem s cepivom Prepandrix o tem vseeno posvetujte s svojim zdravnikom.
• Problems with your brain and nerves such as inflammation of the central nervous system (encephalomyelitis), inflammation of nerves (neuritis) or a type of paralysis known as ‘GuillainBarré Syndrome'. 
• težave z vašimi možgani in živci, kot je vnetje osrednjega živčevja (encefalomielitis), vnetje živcev (nevritis) ali vrsta ohromitve, imenovana Guillain-Barréjev sindrom; • vnetje žil (vaskulitis).
Half dose 
Polovični odmerek
• if you have a bleeding problem or you bruise easily. 
• če imate kakšno motnjo strjevanja krvi ali ste nagnjeni k podplutbam.
In subjects > 60 years of age, the most frequently reported adverse reaction after vaccination was injection site pain (32.6%). 
Pri preiskovancih, starejših od 60 let, je bil najpogosteje zabeleženi neželeni učinek po cepljenju bolečina na mestu injiciranja (32,6 %).
This indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared with H5N1 subtype strains (see section 5.1). 
Indikacija temelji na podatkih o imunogenosti pri zdravih prostovoljcih, starejših od 18 let, po cepljenju z dvema odmerkoma cepiva, pripravljenega iz podtipov sevov H5N1(glejte poglavje 5.1).
• Tingling or numbness of the hands or feet 
• mravljinčenje ali odrevenelost v rokah ali nogah,
Suspension and emulsion for emulsion for injection. 
Suspenzija in emulzija za emulzijo za injiciranje.
Do not have Prepandrix if any of the above apply to you. 
Ne cepite se s cepivom Prepandrix, če karkoli od naštetega velja za vas.
The European Medicines Agency has deferred the obligation to submit the results of studies with Prepandrix in one or more subsets of the paediatric population in influenza infection caused by an influenza strain contained in the vaccine or related to a strain contained in the vaccine. 
Evropska agencija za zdravila je začasno odložila obvezo za predložitev rezultatov študij s cepivom Prepandrix pri eni ali več podskupinah pediatrične populacije za okužbo z gripo, povzročeno s sevom v cepivu, ali s sevom, sorodnim sevu v cepivu(za informacije o pediatrični uporabi glejte poglavje
Therefore, healthcare providers need to assess the benefits and potential risks of administering the vaccine in individuals with thrombocytopenia or any bleeding disorder that would contraindicate intramuscular injection unless the potential benefit outweighs the risk of bleedings. 
Zato mora zdravnik oceniti koristi in možna tveganja uporabe cepiva pri posameznikih s trombocitopenijo ali kakršnokoli motnjo strjevanja krvi,
• Periodic Safety Update Reports 
• Periodična poročila o varnosti (PSUR)
If this applies to you then your vaccination will be postponed until you are feeling better. 
V tem primeru, bo zdravnik cepljenje običajno odložil, dokler ne boste ozdraveli.
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/ 
DATUM ZADNJE REVIZIJE BESEDILA Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu/
If the mixed vaccine is stored in a refrigerator, it should be allowed to reach room temperature (for a minimum of 15 minutes) before each withdrawal. 
Če pripravljeno cepivo shranjujete v hladilniku, ga je treba pred odvzemom posameznega odmerka vsaj 15 minut pustiti, da doseže sobno temperaturo.
In other clinical studies where children 6 months to 17 years received Prepandrix, increases in the frequency of some side effects (including injection site pain, redness and fever) were seen after the second dose in children aged less than 6 years. 
V drugih kliničnih študijah, v katerih so otroci v starosti od 6 mesecev do 17 let dobili cepivo Prepandrix, so pri otrocih, mlajših od 6 let, po drugem odmerku opažali večjo pogostnost nekaterih neželenih učinkov (vključno z bolečino na mestu injiciranja, pordelostjo in zvišano telesno temperaturo).
Redness Swelling Fever (>38°C) Fever (>39°C) - per-dose frequency - per-subject frequency Drowsiness 
Polni odmerek induracija bolečina pordelost oteklost zvišana telesna temperatura (> 38 °C) zvišana telesna temperatura (> 39 °C) - pogostnost na odmerek - pogostnost na preiskovanca zaspanost
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, acute and repeated dose toxicity, local tolerance, female fertility, embryo-fetal and postnatal toxicity (up to the end of the lactation period). 
Predklinični podatki na osnovi običajnih študij farmakološke varnosti, akutne toksičnosti in toksičnosti pri ponavljajočih se odmerkih, lokalne tolerance, plodnosti pri samicah, embrio-fetalne in postnatalne toksičnosti (do konca obdobja laktacije) ne kažejo posebnega tveganja za človeka.
The side effects listed below have happened in the days or weeks after vaccination with other vaccines given routinely every year to prevent flu. 
Neželeni učinki, ki so navedeni spodaj, so se pojavili v dnevih ali tednih po cepljenju z drugimi cepivi,
PHARMACEUTICAL FORM AND CONTENTS Adjuvant emulsion for injection 25 vials: emulsion 
FARMACEVTSKA OBLIKA IN VSEBINA Emulzija adjuvansa za injiciranje 25 vial: emulzija
1 Geometric Mean Titre 
1Geometrična sredina titrov
Doses of 15, 5, 1.7 or 0.6 micrograms of HA were tested in the homologous challenge experiment, and doses of 15, 7.5, 3.8 or 1.75 micrograms of HA were tested in the heterologous challenge experiment. 
V homolognem provokacijskem poskusu so raziskovali odmerke 15, 5, 1,7 ali 0,6 mikrograma HA, v heterolognem provokacijskem poskusu pa odmerke 15, 7,5 3,8 ali 1,75 mikrograma HA.
Excipient with known effect The vaccines contains 5 micrograms thiomersal (see section 4.4). 
Cepivo vsebuje 5 mikrogramov tiomersala (glejte poglavje 4.4).
Like all medicines, this vaccine can cause side effects, although not everybody gets them. 
Možni neželeni učinki Kot vsa cepiva ima lahko tudi to cepivo neželene učinke, ki pa se ne pojavijo pri vseh cepljenih osebah.
It is intended to be given before or during the next influenza (flu) pandemic to prevent flu caused by the H5N1 type of the virus. 
Namenjeno je za preprečevanje gripe, ki jo povzroča tip virusa H5N1, pred ali med naslednjo pandemijo gripe.
After two doses given 21 days or 6 months apart, 96.0% of subjects had a 4-fold increase in serum neutralising antibody titre and 98-100% had a titre of at least 1:80. 
Po dveh odmerkih apliciranih 21 dni ali 6 mesecev narazen je 96,0 % preiskovancev imelo 4-krat večji titer nevtralizacijskih protiteles v serumu in 98-100 % preiskovancev je imelo titer vsaj 1:80.
Active immunisation against H5N1 subtype of Influenza A virus. 
Aktivna imunizacija proti podtipu H5N1 virusa influence A.
Prepandrix should under no circumstances be administered intravascularly. 
Cepiva Prepandrix se v nobenem primeru ne sme injicirati v žilo.
However, in the event of an officially declared influenza pandemic, persons previously vaccinated with one or two doses of Prepandrix that contained HA antigen derived from a different clade of the same influenza subtype as the pandemic influenza strain may receive a single dose of Adjupanrix instead of two doses that are required in previously unvaccinated individuals. 
Celotno cepljenje s cepivom Prepandrix obsega dva odmerka.V primeru uradno razglašene pandemije gripe pa lahko dobijo osebe, predhodno cepljene z enim ali dvema odmerkoma cepiva Prepandrix, ki je vsebovalo HA-antigen iz druge gruče (clade) istega podtipa gripe, kot je pandemski sev, en sam odmerek cepiva Adjupanrix namesto dveh odmerkov, ki sta potrebna za predhodno necepljene osebe.
At day 42, the anti-HA antibody responses were as follows: 
Na 42. dan so bili odzivi anti-HA protiteles naslednji:
There are no data on co-administration of Prepandrix with other vaccines. 
Podatkov o sočasni uporabi cepiva Prepandrix z drugimi cepivi ni.
In each experiment, four groups of six ferrets were immunized intramuscularly with an AS03 adjuvanted vaccine containing HA derived from H5N1/A/Vietnam/1194/04 (NIBRG-14). 
V vsakem poskusu so štiri skupine s šestimi živalmi intramuskularno cepili s cepivom, ki je imelo kot adjuvans AS03 in je vsebovalo HA, pridobljen iz H5N1/A/Vietnam/1194/04 (NIBRG-14).
These side effects may also happen with Prepandrix. 
Ti neželeni učinki se lahko pojavijo tudi pri cepivu Prepandrix.
What Prepandrix looks like and contents of the pack 
Izgled cepiva Prepandrix in vsebina pakiranja
Immune response to A/Vietnam/1194/2004 (D42) 61 to 70 years 
Imunski odziv proti A/Vietnam/1194/2004 (D42) 61 do 70 let
NAME OF THE MEDICINAL PRODUCT Emulsion for emulsion for injection for Prepandrix 
IME ZDRAVILA Emulzija za emulzijo za injiciranje za Prepandrix
Prepandrix contains thiomersal 
Cepivo Prepandrix vsebuje tiomersal
- If you get any side effects, talk to your doctor. 
- Če opazite katerikoli neželeni učinek, se posvetujte s svojim zdravnikom.
Very limited data in seronegative subjects >80 years of age (N=5) showed that no subject achieved seroprotection following two administrations of a single dose of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Vietnam/1194/2004 (H5N1). 
Zelo omejeni podatki pri seronegativnih preiskovancih, starejših od 80 let (n = 5), so pokazali, da noben preiskovanec ni dosegel serološke zaščite po dvakratni uporabi enega odmerka cepiva z adjuvansom AS03 z vsebnostjo 3,75 µg HA pridobljeno iz A/Vietnam/1194/2004 (H5N1).
In clinical trials in which subjects (N=201) received Prepandrix containing 3.75 microgram HA/AS03 of A/Indonesia/05/2005 (H5N1) strain, the types and frequencies of adverse reactions were comparable with those reported below. 
V kliničnem preskušanju, v katerem so preiskovanci (n = 201) dobili cepivo Prepandrix, ki je vsebovalo 3,75 mikrograma HA/AS03 seva A/Indonesia/05/2005 (H5N1), so bile vrste in pogostnosti neželenih učinkov primerljive tistim, ki so navedene spodaj.
Blood and lymphatic system disorders Common: lymphadenopathy 
Bolezni krvi in limfatičnega sistema
Therefore monitoring of temperature and measures to lower the temperature (such as giving paracetamol or other medicines that lower fever) after each dose are recommended. 
Zato je otroku po vsakem odmerku cepiva priporočljivo spremljati telesno temperaturo in uporabiti ukrepe za njeno znižanje (npr. otroku dati paracetamol ali drugo zdravilo za znižanje zvišane telesne temperature).
List of adverse reactions Adverse reactions reported are listed according to the following frequency: 
Opisani neželeni učinki so navedeni po naslednjih skupinah pogostnosti: Pogostnosti so navedene kot:
2 % of subjects with titres ≥1:28 
1geometrična sredina titrov 2% preiskovancev s titri ≥1:28
If you get any side effects, talk to your doctor. 
Če opazite katerikoli neželeni učinek, se posvetujte s svojim zdravnikom.
The seroprotection at month 6, 12 and 24 were as follows: 
Deleži serološke zaščite 6., 12. in 24. mesec so bili:
21 days after 2nd dose N=48 
21 dni po drugem odmerku n=48
Seroprotection rate 
Delež serološke zaščite proti
In addition, 44.8% and 56.1% of subjects in respective dose groups had a 4-fold increase in serum neutralising antibody titres from day 0 to day 42 and 96.6% and 100% of subjects had a titre of at least 1:80 at day 42. 
Poleg tega je imelo v posameznih odmernih skupinah 4-kraten porast titrov nevtralizirajočih protiteles v serumu od dneva 0 do 42. dneva 44,8 % in 56,1 % preiskovancev in titer vsaj 1:80 96,6 % in 100 % preiskovancev
Suspension: multidose vial containing the antigen, Emulsion: multidose vial containing the adjuvant. 
Cepivo Prepandrix je na voljo v dveh vsebnikih: suspenzija: večodmerna viala z antigenom, emulzija: večodmerna viala z adjuvansom.
Your doctor or nurse will give you Prepandrix. 
S cepivom Prepandrix vas bo cepil zdravnik ali medicinska sestra.
21 days after 1st dose N=55 
21 dni po prvem odmerku n=55
In a clinical study, children 3 to 9 years of age have received either two adult (0.5 ml) or two half adult (0.25 ml) doses of a similar vaccine containing A/Vietnam/1194/2004. 
V klinični študiji so otroci, stari od 3 do 9 let, prejeli dvakrat bodisi odmerek za odrasle (0,5 ml) bodisi polovični odmerek za odrasle (0,25 ml) podobnega cepiva, ki je vsebovalo sev A/Vietnam/1194/2004.
• if you have previously had a sudden life-threatening allergic reaction to any ingredient of this vaccine (listed in section 6) or to anything else that may be present in very small amounts such as: egg and chicken protein, ovalbumin, formaldehyde, gentamicin sulphate (antibiotic) or sodium deoxycholate. 
• če ste kdaj imeli nenadno, življenjsko ogrožajočo alergijsko reakcijo na katerokoli sestavino tega cepiva (navedeno v poglavju 6) ali na karkoli, kar je lahko prisotno v zelo majhnih količinah, kot so: jajčne in piščančje beljakovine, ovalbumin, formaldehid, gentamicinijev sulfat (antibiotik) ali natrijev deoksiholat.
How to store Prepandrix 
Kako uporabljati cepivo Prepandrix
Clinical studies have evaluated the incidence of adverse reactions in approximately 5,000 subjects 18 years old and above who received Prepandrix containing A/Vietnam/1194/2004 (H5N1) strain with at least 3.75 µg HA. 
S kliničnimi študijami so ocenili pojavnost neželenih učinkov pri približno 5.000 preiskovancih, starih 18 let in več cepljenih s cepivom Prepandrix, ki je vsebovalo sev A/Vietnam/1194/2004 (H5N1) z vsaj 3,75 µg HA.
2.5 ml After mixing with adjuvant emulsion: 10 doses of 0.5 ml) 
2,5 ml Po premešanju z emulzijo adjuvansa: 10 odmerkov po 0,5 ml.
Month 6 N=48 
6. mesec n=48
The seroprotection rates 6, 12, 24 and 36 months after the first dose were as follows: anti-HA antibody 
Deleži serološke zaščite 6, 12 in 24 mesecev po cepljenju so bili: anti-HA protitelesa
Month N=35 
12. mesec n=35
Regardless of whether one or two doses of priming vaccine had been given 6 months earlier, the seroprotection rates against A/Indonesia were >80% after a dose of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Vietnam/1194/2004 and the seroprotection rates against A/Vietnam were >90% after a dose of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Indonesia/05/2005. 
Ne glede na to, ali sta bili 6 mesecev prej uporabljena eden ali dva odmerka primarnega cepiva so bili deleži serološke zaščite proti A/Indonesia po odmerku cepiva z adjuvansom AS03 z vsebnostjo 3,75 µg HA pridobljeno iz A/Vietnam/1194/2004 > 80 %, deleži serološke zaščite proti A/Vietnam po odmerku cepiva z adjuvansom AS03 z vsebnostjo 3,75 µg HA pridobljeno iz A/Indonesia/05/2005 pa > 90 %.
Contents of the pack and other information 
Shranjevanje cepiva Prepandrix Vsebina pakiranja in dodatne informacije
Immune response against A/Indonesia/05/2005 (H5N1) In a clinical study (Q-Pan-H5N1-001) in which two doses of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Indonesia/05/2005 were administered on days 0 and 21 to 140 subjects aged 18-60 years, the anti-HA antibody responses were as follows: anti-HA antibody 
Imunski odziv proti A/Indonesia/05/2005 (H5N1) V klinični študiji (Q-Pan-H5N1-001), v kateri je 140 preiskovancev, starih od 18 do 60 let, dobilo na dan 0 in 21 dva odmerka cepiva z adjuvansom AS03 z vsebnostjo 3,75 µg HA pridobljeno iz A/Indonesia/05/2005, je bil odziv anti-HA protiteles naslednji: anti-HA protitelesa
How Prepandrix works 
Kako deluje cepivo Prepandrix
The vaccine should be administered in accordance with the recommended posology (see section 3 “How Prepandrix is given”). 
Po mešanju je količina cepiva Prepandrix v viali vsaj 5 ml.. Cepivo je treba uporabiti v skladu s priporočenim odmerjanjem (glejte poglavje 3 "Kako uporabljati cepivo Prepandrix").
Caution is needed when administering this vaccine to persons with a known hypersensitivity (other than anaphylactic reaction) to the active substance, to any of the excipients listed in section 6.1, to thiomersal and to residues (egg and chicken protein, ovalbumin, formaldehyde, gentamicin sulphate and sodium deoxycholate). 
Previdnost je potrebna pri cepljenju oseb z znano preobčutljivostjo (poleg anafilaktične reakcije) za zdravilno učinkovino, ali katerokoli pomožno snov navedeno v poglavju 6.1, tiomersal ali zaostanke (jajčne ali piščančje proteine, ovalbumin, formaldehid, gentamicinijev sulfat ali natrijev deoksiholat).
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Adjuvant emulsion for Prepandrix 
IME ZDRAVILA IN POT(I) UPORABE Emulzija adjuvansa za Prepandrix i.m.